Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
    about 7 hours ago
  • New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
    about 7 hours ago
  • Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
    about 11 hours ago
  • New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
    about 11 hours ago
  • The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
    about 1 day ago

Please share Science & Enterprise

Software Designed to Model, Visualize Brain Circuits

NetPyNE GUI screen

An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits. . . . → Read More: Software Designed to Model, Visualize Brain Circuits

Gene Therapy Delivery Tech Licensed in $1.8B Deal

DNA puzzle

A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche. . . . → Read More: Gene Therapy Delivery Tech Licensed in $1.8B Deal

Individual Cells Explored with Virtual Reality

vLume image

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

New Funds Advance Hand-Wrist Neural Rehab Device

Neurons illustration

Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use. . . . → Read More: New Funds Advance Hand-Wrist Neural Rehab Device

New Company IDs Drugs Targeting Cancer Cell Networks

Cancer magnified

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Biotech, Analytics Companies Partner on Drug Discovery

Population genetics

A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases. . . . → Read More: Biotech, Analytics Companies Partner on Drug Discovery

Study Testing Wearables Data for Covid-19 Clues

Smart watch with PhysIQ app

A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users. . . . → Read More: Study Testing Wearables Data for Covid-19 Clues

Dexcom, UVirginia Partner on Diabetes Technology

Artificial pancreas system

Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes . . . → Read More: Dexcom, UVirginia Partner on Diabetes Technology

Cancer Screening Analytics Company Acquired in $8B Deal

Blood sample vials

A company creating a blood test to screen for multiple types of cancer is being acquired by genomics analytics company Illumina for $8 billion in cash and stock. . . . → Read More: Cancer Screening Analytics Company Acquired in $8B Deal

Antibody Discovery Company Forms, Partners on Covid-19

Network pointer

A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19